Jul 20 2017 Flashing Briefing - a podcast by Affygility Solutions, LLC

For July 20, 2017. Artificial Intelligence is about to play a major role in the pharmaceutical industry. On July 2nd of this year, Glaxo-Smith-Kline revealed a 43-million dollar deal in which they will use A.I. to make the process of discovering new drugs easier. The goal is to reduce the time it takes from identifying a target for disease intervention to finding a molecule that acts against it. He hopes to bring it from an average 5 and a half years today to just one year in the very near future.

Further episodes of Biopharma EHS

Further podcasts by Affygility Solutions, LLC

Website of Affygility Solutions, LLC